Full Event Guide
5 Key Insights You Cannot Miss!
- Understand disease heterogeneity with AstraZeneca
- Explore drug development outcomes from phenomapping with Cyclerion Therapeutics
- Review EMPEROR-Preserved outcomes & success with Boehringer Ingelheim
- Accelerate proof of concept decisions & overcome translational challenges with Bayer and Cardiobiopharma
- Investigate & manipulate the relationship between HFpEF & multimorbidities with Novo Nordisk